Therefore, increased IGFBP-2 binding to IGF-2 could lead to altered receptor activation and signaling pathways, which are especially important in CI and pathological states such as cancer, where IGFs play a role in promoting cell proliferation [17,37]. The gene discussed is IGFBP2; the disease is cancer.